Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More![hero-decor](/images/demo/halfbrain.png)
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn MoreOn May 24, the Maastricht Psychedelic Research Team organized a mini-symposium on psychedelics. We welcomed two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also had several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg).
Click below to watch the entire symposium
Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.
Read The PaperWe're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All StudiesCognition, Synthetic Cannabinoids, Drugs and Driving
I began my Ph.D. journey in 2001 at the Faculty of Psychology at the University of Maastricht. My research focused on investigating the sedating and stimulating effects of antihistamines, with a particular emphasis on their...
Psychedelics, fMRI/MRS, Idiosyncracy
I am PhD candidate with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.
Microdosing, Cognition, Nutrition
My research focuses on the neurobiology of flexible cognition, empathy, and well-being.
I have a long standing interest in unravelling the therapeutic mechanisms of Psychedelics, and in this project I will investigate the effect of Psychedelic drug exposure in humans on miRNA’s transported in neuron-derived Extracellular Vesicles...
I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.
Plasticity, Psychedelics, Neuroadaptations
My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.
Cannabinoids, Neuroimaging, Consciousness
Coming from a background of psychology and clinical neuroscience, I developed a strong interest in altered states of the mind as in mediation or yoga practices.
Stress Resilience, Psychedelics, Cognitive biases
My research focuses on the effects of stress, sleep deprivation, on cognitive biases, by using the transdiagnostic rDOC approach, and see whether psychedelics such as LSD, Psilocybin and even non-hallucinogenic psychedelics can reverse these effects.
My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.
vision, retinofugal, tripping, hallucinations, Psychedelics, visual
→creativity, divergent thinking, Ayahuasca, convergent thinking
→Cannabis, Cognition, Psychomotor
→We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.